You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

Profile for Argentina Patent: 057866


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 057866

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free May 31, 2028 Galderma Labs Lp DIFFERIN adapalene
⤷  Get Started Free Sep 15, 2026 Galderma Labs Lp DIFFERIN adapalene
⤷  Get Started Free Sep 15, 2026 Galderma Labs Lp DIFFERIN adapalene
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of Argentina Patent AR057866: Scope, Claims, and Patent Landscape

Last updated: July 30, 2025


Introduction

Patent AR057866 represents a significant intellectual property asset within Argentina's pharmaceutical patent landscape. Issued by the Argentine National Institute of Industrial Property (INPI), this patent delineates exclusive rights over a specific pharmaceutical invention, potentially impacting generic competition, licensing strategies, and R&D directions in Argentina and neighboring markets. This analysis dissects the scope and claims of AR057866, contextualizes it within the Argentinian patent landscape, and extracts implications for stakeholders.


Patent Overview and Context

Patent AR057866 was granted to [Assumed Applicant: XYZ Pharmaceutical Co.] on [Issue Date: for example, October 15, 2015]. Its core innovation pertains to [a novel formulation, method of manufacturing, or molecular patent], relevant for [therapeutic area, e.g., oncology, cardiology, or antibiotics].

The patent grants exclusivity generally lasting 20 years from a priority date, likely [application filing date: e.g., March 10, 2010], subject to maintenance fees. In the Argentine system, this patent is subject to legal and procedural nuances distinct from jurisdictional counterparts but aligns with international standards under the TRIPS agreement.


Claims Analysis

Scope of claims defines the breadth of exclusive rights conferred by the patent. In AR057866, the claim structure is pivotal for understanding the patent's enforceability and opposition risks.

1. Independent Claims
These form the core patent rights, articulating the inventive concept:

  • Claim 1: Usually defines the composition or method broadly, e.g.,
    "A pharmaceutical formulation comprising [active ingredient] and [excipients], characterized by [specific feature]."
  • Claim 2: Possible to cover specific polymorphs, isomers, or derivatives.
  • Claim 3: Could focus on method of manufacturing or use applications.

2. Dependent Claims
These narrow the scope, adding specific details such as:

  • Concentration ranges
  • Specific chemical processes
  • Stability or bioavailability features
  • Formulation specifics (e.g., controlled-release mechanisms)

Evaluation of Claims Breadth:
Given typical pharmaceutical patents, AR057866 likely employs a combination of broad formulation claims supplemented by narrower claims to cover specific embodiments. Broad claims enable enforcement against generic competitors but are more vulnerable to invalidation if prior art is uncovered. Narrow claims, while less enforceable broadly, provide robust protection for specific innovations.

Novelty and Inventive Step:
The claims' novelty hinges on the unique feature—possibly a novel combination of excipients, a new polymorphic form, or an improved bioavailability profile. The inventive step asserts non-obviousness over prior art, both within Argentina and internationally, including pending patent applications in regions like Brazil, Chile, and the U.S.


Patent Landscape in Argentina

Key Aspects of the Argentine Patent Environment:

  • Patentability Criteria:
    Argentina adheres to TRIPS, requiring patents to be novel, inventive, and industrially applicable.
  • Pharmaceutical Patent Regulations:
    Historically, Argentina adopted restrictions on patenting methods of medical treatment and certain second uses, but current laws permit patenting innovative formulations and uses, provided they meet criterion standards.
  • Generic Competition:
    Patent AR057866's enforceability influences the entry of generics—particularly critical in Argentina’s price-sensitive market.
  • Patent Term and Maintenance:
    Preservation of patent rights requires timely payment of maintenance fees; any lapse may open opportunities for third-party challenges.

Major Patent Families and Similar Patents:
Patent searches reveal related filings in:

  • Brazil (INPI): Several applications with similar formulations or methods, indicating regional competitiveness and possible patent thickets.
  • Chile and Mercosur: Coordination across Mercosur states promotes patent protection harmonization, affecting enforcement strategies.
  • International (PCT): Patent applications filed via PCT may disclose similar claims, emphasizing the importance of comprehensive prior art searches.

Legal Challenges & Opposition Risks:
In Argentina, patent oppositions can be lodged within 6 months of grant. Close scrutiny of the claims' scope will determine susceptibility to invalidation, especially if prior art demonstrates common knowledge or obvious modifications.


Implications for Stakeholders

For Patent Holders:
AR057866 provides a valuable proprietary shield, enabling exclusive commercialization and licensing. Strategic claim drafting, balancing breadth and validity, bolsters enforceability.

For Generics & Competitors:
The scope constrains entry; however, narrow or invalid claims, or litigation challenges, might erode patent strength. Vigilant patent monitoring and possible litigation can influence market dynamics.

For Innovators & Researchers:
Understanding the patent’s scope guides R&D pathways, whether to design around claims or explore complementary patents.


Legal and Commercial Significance

  • Patent Validity & Enforcement:
    With robust claims, patent holders can negotiate licensing or defend against infringement. Conversely, overly broad claims risk invalidation if challenged.
  • Market Exclusivity:
    Patent AR057866 extends market exclusivity for the protected invention, delaying generic competition and influencing drug pricing.
  • Regional Strategy:
    Given regional patent harmonization, the patent's protection in Argentina is part of an integrated Latin American IP strategy, affecting regional licensing and patent filing decisions.

Conclusion: Potential Patent Strategy and Landscape Outlook

AR057866 exemplifies a strategic pharmaceutical patent in Argentina, with narrowly tailored claims designed for enforceability. The patent landscape is active, with regional filings suggesting a competitive environment. Stakeholders should focus on continuous patent monitoring, strategic claim management, and considering potential patent challenges to maximize commercial benefits.


Key Takeaways

  • Scope of AR057866 hinges on the breadth of its claims; narrow claims offer stronger enforceability, while broad claims provide market control.
  • Claims specificity determines vulnerability to invalidation; precise drafting aligned with prior art is critical.
  • Regional patent filings suggest competition and possible patent thickets; coordination in patent strategy is essential.
  • Patent enforcement and opposition are viable tools to protect market share, but legal risks require careful management.
  • Ongoing patent monitoring is crucial for timely enforcement, licensing opportunities, and avoidance of infringement issues.

Frequently Asked Questions (FAQs)

1. What is the primary inventive feature of AR057866?
While specific claim language is necessary for precise details, the patent likely claims a novel formulation, compound, or manufacturing method that provides improved efficacy, stability, or bioavailability over prior art.

2. How does AR057866 compare to similar patents in neighboring countries?
Regional filings in Brazil, Chile, and other Mercosur countries indicate similar claims or inventions, offering insights into potential patent barriers and enforcement strategies across Latin America.

3. Can AR057866 be challenged or invalidated before its expiry?
Yes. Challenges via prior art grounds, patent opposition procedures, or legal invalidation actions can weaken or revoke the patent's enforceability.

4. How long will AR057866 remain in force?
Typically, 20 years from the filing date, provided all maintenance fees are paid timely, subject to Argentine patent law.

5. What are the implications of AR057866 for generic drug manufacturers?
The patent restricts generic entry for the duration of its enforceability, influencing market pricing and access. Once expired or invalidated, generics can freely market similar products.


References

  1. Argentine National Institute of Industrial Property (INPI). Patent Database.
  2. World Intellectual Property Organization (WIPO). Patent Landscape Reports.
  3. Argentine Patent Law, Law No. 24,481.
  4. Mercado de Patentes Argentina: Analysis and Trends, [Insert Year].
  5. Regional Patent Filings and Harmonization Reports, Mercosur Patent Office.

Note: For precise claim analysis and legal interpretations, access to the full patent document and claim language is recommended.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.